Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Different rheumatological diseases can cause specific skin problems.

TGF-β1 and TNF-α contribute to lung damage after radiation.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

An 18-year-old woman was diagnosed with a rare skin condition called Pityriasis rubra pilaris.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Most children with MIS-C showed significant improvement by 6 months.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The patient improved after antiviral treatment for a viral infection.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Skin issues can signal substance use, helping early detection and treatment.